Pharmacy |
| ||
|
Prescription Drugs 9 |
|
| ||
Home » Prescription Drugs 9
HYDERGINE Generic Co Dergocrine Mesylate Hyzaar Forte Generic Losartan and Hydrochlorthiazide Hyzaar Generic Losartan and Hydrochlorthiazide Imdur Generic Isosorbide Mononitrate Isordil Generic isosorbide Dinitrate Itoprid Generic Itopride hydrochloride Januvia Generic Sitagliptin Phosphate Kamagra Oral Jelly Banana Flavor Viagra Kamagra Oral Jelly Grape Flavor Viagra KAMAGRA ORAL JELLY Mint Flav Viagra KAMAGRA ORAL JELLY Orange Flav Viagra Kamagra Oral Jelly Strawberry Flavor Viagra Kenacort Oral Paste Kenalog in Orabase Lamictal DC Generic Lamotrigine Lamisil Cream Generic Terbinafine Lamisil Derm Gel Generic Terbinafine Lamisil Jock Itch Generic Terbinafine Lamisil Once 4gm Generic Terbinafine Lamisil Spray Generic Terbinafine Lantus Solostar Lantus OptiClik Cartridge
Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.
| ||
